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Hidradenitis suppurativa (HS) is an inflammatory skin 
disease characterized by painful nodules, abscesses and 
sinus tracts. The disease is located primarily in the apo-
crine gland-bearing skin, including the armpits and groins 
(1). Previous studies have shown that follicular occlusion 
is present in the majority of patients at an early stage 
of the disease (2–5); however, the driving mechanism 
behind this follicular occlusion is unknown. Recently, 
diminished periodic acid-Schiff (PAS) staining was found 
in the basement membrane zone (BMZ) of the sebofol-
licular junction (SFJ) at the folliculopilosebaceous units 
(FPSU) in perilesional HS skin (6). The authors suggest 
that the PAS-negative gaps represent primary defects in 
the BMZ, leading to fragility of the hair follicle. Diminis-
hed expression in one of the glycoproteins in the BMZ of 
the SFJ might explain these PAS-negative gaps; however, 
there was no staining for specific glycoproteins in this 
study. Therefore, we investigated the expression of the 
most important BMZ components, including type XVII 
collagen, type VII collagen, laminin-332, and integrin 
α6β4, of the follicular epidermis relative to the interfol-
licular epidermis in HS and compared the expression 
ratio with that of healthy controls. 
MATERIALS AND METHODS
Skin samples were obtained from perilesional skin of patients 
with HS who underwent surgery (n = 17). Biopsies 4-mm thick 
were obtained from axillary skin of 8 healthy volunteers. The 
study was ethically approved by the local review board. PAS, 
and immunofluorescence (IF) staining for type XVII colla-
gen, type VII collagen, laminin 332, integrin α6 and β4 were 
performed on all skin samples (for complete details see Ap-
pendix S11). Staining intensities were measured at 5 segments 
of the FPSU: (i) the interfollicular epidermis (IFE); (ii) the 
superior segment of the hair follicle; (iii) the inferior segment 
of the hair follicle; (iv) the sebofollicular junction (SFJ); and 
(v) the sebaceous gland. The superior segment was defined as 
the part of the hair follicle extending from the IFE to the SFJ, 
the inferior segment as the part extending from the SFJ to the 
bulb. The SFJ was defined as the transition zone from the hair 
follicle to the sebaceous gland. 
The intensity of the stainings at the aforementioned individual 
segments were analysed using Image J software. The ratio of 
individual segments to the IFE was calculated for both the PAS 
and IF stainings, with the IFE serving as an internal control for 
each skin sample. A Mann-Whitney U test was used to compare 
the differences in these ratios between patients and controls.
RESULTS
Skin biopsies of 10 patients and 2 controls were excluded 
due to the lack of an associated sebaceous gland. In total, 
biopsies of 7 HS patients and 6 controls were studied. 
The IFE showed a continuous and regular PAS 
staining pattern in all biopsies with a mean intensity of 
143.8 pixels (standard deviation [SD] 11.6) in controls 
Increased Expression of Integrin α6β4 in the Basement Membrane Zone Lining the Sebaceous Glands 
in Hidradenitis Suppurativa
Janine L. Blok, Ineke C. Janse, Barbara Horváth and Marcel F. Jonkman
Department of Dermatology, University Medical Center Groningen, Hanzeplein 1, NL-9700 RB Groningen, The Netherlands. E-mail: j.l.dickinson-blok@
umcg.nl
Accepted Jun 25, 2015; Epub ahead of print Jun 30, 2015
Fig. 1. Periodic acid–Schiff (PAS) and immunofluorescence (IF) staining of the interfollicular epidermis (IFE) and sebofollicular junction/sebaceous 
gland (SFJ/SG) in control and patient skin. There were no differences in the intensity of the PAS staining between the IFE and the SFJ/SG in both controls 




and 150.0 pixels (SD 10.5) in patients. Therefore, the 
IFE served as a suitable internal control. There were no 
statistically significant differences between the ratios 
of the mean intensity of the PAS staining at the indivi-
dual segments of the FPSU to the IFE in patients and 
controls (Figs 1 and 2).
For type VII collagen, type XVII collagen, and lami-
nin 332 staining, no statistically significant differences 
were found between patients and controls in the ratios 
of the mean staining intensity at the individual FPSU 
segments to the IFE.
For integrin β4 and α6 staining, the mean intensity 
of integrin β4 at the sebaceous gland declined compa-
red with the IFE in both patients and controls (Figs 1 
and 2). The ratio of the mean intensity of integrin β4 
at the sebaceous gland to the IFE was significantly 
higher in patients (0.41) compared with controls (0.14) 
(p = 0.004). This implies that integrin β4 expression at 
the sebaceous gland was relatively higher in patients. 
IF staining for integrin α6 also revealed a significantly 
(p =0.011) higher level of expression at the sebaceous 
gland in HS compared with controls (Figs 1 and 2). It is 
plausible that the expression patterns of integrin α6 and 
β4 followed the same pattern, since they are dimerized 
in the integrin α6β4-complex. The relative expression 
of integrin α6β4 was not altered at the remaining FPSU 
segments in HS compared with controls.
DISCUSSION
This study demonstrates a relative upregulation of 
integrin α6β4 along the BMZ of sebaceous glands in 
HS patients.
A relatively large number of HS skin samples lacked 
an associated sebaceous gland in this study (58.8% 
(10/17) vs. 25.0% [2/8] in controls). This is in accordan-
ce with the findings of Kamp et al. (2), that sebaceous 
glands are frequently lacking or have a diminished 
volume in perilesional HS skin. In contrast to Danby 
et al. (6), reduced PAS positivity at the SFJ in HS was 
not observed, neither did we find any differences in PAS 
positivity within the remaining hair follicle segments. 
One may speculate about the cause and consequences 
of integrin α6β4 upregulation in HS. Integrins are a 
family of heterodimeric glycosylated transmembrane 
receptors. They come primarily to expression in organs 
lined with stratified epithelium, such as the skin and 
lungs. In skin, the β4 integrins are primarily found in the 
BMZ. In addition to their significant adhesive function, 
integrins are important signalling molecules that have 
bidirectional actions. They show affinity with several 
extracellular proteins and are therefore involved in a va-
riety of pathological processes, including oncogenesis, 
immune responses and inflammatory reactions (3, 4).
Upregulation of integrins α6β4, as found in the current 
study, was also described in bacterial-infected pulmonary 
tissue (5). Similar to lung tissue, changes in the bacterial 
community may be responsible for the integrin α6β4 
upregulation we found in patients with HS (5). From this 
viewpoint, integrins may function as pattern-recognition 
receptors (PRRs), which, upon interaction with bacteria, 
induce cellular responses that activate the innate immune 
response (3). Also in Crohn’s disease, which is presu-
med to have a pathogenesis similar to HS, integrins are 
thought to contribute to the aberrant immune response 
(7, 8). Moreover, anti-α4-integrins have shown to be 
effective in the treatment of Crohn’s disease (8). The 
role of bacteria in the pathogenesis of HS is a topic of 
ongoing investigation (9). However, in addition to the 
possible role in integrin upregulation, alterations in the 
skin’s microbioma may also explain why HS is mainly 
localized in the body folds, as these relatively moist areas 
harbour a different bacterial community from that found 
in other areas of the body (10, 11). 
Finally, increased expression of α6β4 may also con-
tribute to the development of squamous cell carcinoma 
(SCC), which is a well-known complication of HS (12, 
13). In fact, mice with aberrant α6β4 expression showed 
a greater infiltration of immunosuppressive cells during 
tumour promotion, a phenomenon that may contribute 
to the susceptibility of SCC formation (13).
In conclusion, this study demonstrates upregulation 
of integrin α6β4 in sebaceous glands of patients with 
HS. This upregulation could result from alterations in 
Fig. 2. Ratio of periodic acid–Schiff (PAS) and integrin α6β4 staining in various folliculopilosebaceous (FPSU) segments compared with the interfollicular 
epidermis (IFE) in patients with hidradenitis suppurativa (n = 7) and in 6 healthy controls. The bars represent the ratio of the mean PAS and integrin α6β4 
staining intensities of the individually assessed FPSU segments to the IFE increased α6β4 expression of integrins β4 and α6 in patients’ sebaceous glands 
(SG). SS: superior segment; SFJ: sebofollicular junction; IS: inferior segment. (*p = 0.004/0.011).
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the skin microbioma and may contribute to the inflam-
matory reaction seen in HS as well as to the increased 
risk of SCC development in HS. Characterization of the 
skin microbioma in greater detail could provide further 
insight into the role of bacteria in HS and may provide a 
rationale for specific antibiotic treatments. Integrin α6β4 
could be a putative treatment target for HS in the future. 
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